Strongbridge Biopharma (SBBP) – Analyst Ratings
-
Xeris Pharmaceuticals (XERS) PT Raised to $12 at Piper Sandler After Model Update
-
Craig-Hallum Downgrades Strongbridge Biopharma (SBBP) to Hold
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SBBP Stock Lookup